Related Experiment Video

Updated: Jul 20, 2026

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

Targeting DNA methylation in cancer

Moshe Szyf1

  • 1Department of Pharmacology and Therapeutics, McGill University, 3655 Sir William Osler Promenade, Montreal PQ H3G 1Y6 Canada. moshe.szyf@mcgill.ca

Bulletin Du Cancer
|September 19, 2006
PubMed

Insights

Epigenetic modifications, including DNA methylation changes, drive cancer progression. Both DNA hypermethylation and hypomethylation play critical roles in cancer development and metastasis, offering therapeutic targets.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cancer development involves altered gene expression.
  • Epigenetic modifications, such as DNA methylation, significantly influence gene expression in cancer.
  • The epigenome, including histone modifications and DNA methylation patterns, is crucial for cellular function.

Purpose of the Study:

  • To explore the role of epigenetic modifications, specifically DNA methylation, in cancer growth and metastasis.
  • To differentiate the roles of DNA hypermethylation and hypomethylation in tumorigenesis.
  • To discuss the therapeutic potential of targeting DNA methylation in cancer treatment.

Main Methods:

  • Review of existing literature on cancer epigenetics and DNA methylation.
  • Analysis of gene expression changes associated with epigenetic modifications in cancer.
  • Examination of the impact of DNA methylation patterns on tumor suppressor genes and invasion-related genes.

Main Results:

  • Cancer progression is linked to altered DNA methylation patterns, including regional hypermethylation and genome-wide hypomethylation.
  • Hypermethylation of tumor suppressor genes leads to their silencing.
  • Hypomethylation contributes to the activation of genes promoting invasion and metastasis.

Conclusions:

  • Epigenetic alterations, particularly in DNA methylation, are fundamental to cancer.
  • Both hypermethylation and hypomethylation are critical mechanisms in cancer, with distinct roles in gene silencing and activation of pro-metastatic genes.
  • Targeting DNA methylation pathways presents a promising therapeutic strategy for cancer treatment.

More Related Videos

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer07:50

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer

Published on: September 18, 2020

Methyl-binding DNA capture Sequencing for Patient Tissues08:40

Methyl-binding DNA capture Sequencing for Patient Tissues

Published on: October 31, 2016

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...